/ACMSY
ACMSY Stock - AccuStem Sciences Limited
Healthcare|Medical - Diagnostics & ResearchOTC
$0.13-7.14%
$0.01 (-7.14%) • Apr 24
52
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.7
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.14
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ACMSY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.13 – $0.13
TARGET (TP)$0.15
STOP LOSS$0.12
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.00
52W High$0.56
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A |
| Operating Income | $-1,505,000 | $-2,051,000 | $-3,746,000 | $-671,000 |
| Net Income | $-1,505,000 | $-2,051,000 | $-3,746,000 | $-671,000 |
| Net Margin | N/A | N/A | N/A | N/A |
| EPS | $-0.13 | $-0.18 | $-0.34 | $-0.07 |
Company Overview
Accustem Sciences Limited engages in the genomic signature-based assay business for the prognosis of early and late recurrence of ER+/HER2 breast cancer in early stage breast cancer patients. The company was incorporated in 2020 and is based in London, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ACMSYLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about ACMSY
What is ACMSY's current stock price?
AccuStem Sciences Limited (ACMSY) is currently trading at $0.13 per share. The stock has moved -7.14% today.
What is the analyst price target for ACMSY?
No analyst price targets are currently available for this stock.
What sector is AccuStem Sciences Limited in?
AccuStem Sciences Limited operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.
What is ACMSY's market cap?
AccuStem Sciences Limited has a market capitalization of N/A, making it a small-cap company.
Does ACMSY pay dividends?
No, AccuStem Sciences Limited does not currently pay a dividend to shareholders.